Immunogen (IMGN) Tops Q3 EPS by 6c

November 2, 2023 6:33 AM EDT

Immunogen (NASDAQ: IMGN) reported Q3 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $113.4 million versus the consensus estimate of $103.68 million.

For earnings history and earnings-related data on Immunogen (IMGN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings